The safety and efficacy of calcium channel blockers in hypertension are not uniform and depend on their specific kinetic and pharmacologic properties.
As the safety of calcium channel blockers continues to be debated, it is important to realize that not all calcium channel blockers are alike. Safety, and efficacy, depend on the kinetic as well as the pharmacologic properties of the drug.
No takes yet. Share an insight, caveat, or question.
Murray Epstein (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: